bufogenin has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Chen, X; Deng, C; Du, S; Guo, T; Huang, J; Lu, M | 1 |
| Li, F; Liu, YG; Wang, LQ; Wen, DH; Xia, YC; Yin, H; Yu, BT; Zha, JH | 1 |
2 other study(ies) available for bufogenin and Lung Neoplasms
| Article | Year |
|---|---|
Cinobufotalin Induces Ferroptosis to Suppress Lung Cancer Cell Growth by lncRNA LINC00597/hsa-miR-367-3p/TFRC Pathway via Resibufogenin.
Topics: Cell Proliferation; Ferroptosis; Humans; Lung Neoplasms; MicroRNAs; Receptors, Transferrin; RNA, Long Noncoding | 2023 |
Resibufogenin suppresses growth and metastasis through inducing caspase-1-dependent pyroptosis via ROS-mediated NF-κB suppression in non-small cell lung cancer.
Topics: Acetylcysteine; Antioxidants; Bufanolides; Carcinoma, Non-Small-Cell Lung; Caspase 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Lung Neoplasms; NF-kappa B; Pyroptosis; Reactive Oxygen Species | 2021 |